Viridian Therapeutics Inc (VRDN)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current VRDN market cap is 905.96M. The company's latest EPS is USD -3.7210 and P/E is -3.81.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 98k | 72k | 72k | 72k | 72k |
| Operating Income | -72.47M | -59.28M | -51.22M | -71.48M | -55.9M |
| Net Income | -68.15M | -55.06M | -47.66M | -66.86M | -48.54M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.46M | 1.05M | 2.96M | 1.77M | 314k |
| Operating Income | -41.98M | -110.38M | -79.73M | -134.3M | -254.45M |
| Net Income | -41.87M | -110.72M | -79.41M | -129.87M | -237.73M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 386.64M | 351.47M | 328.76M | 490.42M | 630.38M |
| Total Liabilities | 36.09M | 35.61M | 45.18M | 48.4M | 47.85M |
| Total Equity | 350.55M | 315.86M | 283.58M | 442.02M | 582.53M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 30.26M | 131.26M | 203.71M | 435.09M | 490.42M |
| Total Liabilities | 14.51M | 11.22M | 15.99M | 40.03M | 48.4M |
| Total Equity | 15.75M | -60.76M | 187.72M | 395.06M | 442.02M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -61.97M | -107.19M | -146.17M | -184.17M | -45.22M |
| Investing | -13.3M | 27.42M | 75.46M | -94.25M | -143.05M |
| Financing | 8.2M | 11.27M | 26.73M | 225.67M | 177.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -36.06M | -29.78M | -54.58M | -93.84M | -184.17M |
| Investing | 28.23M | -50.48M | -74.29M | -115.13M | -94.25M |
| Financing | 70k | 101.31M | 125.28M | 322.24M | 225.67M |
| Market Cap | 905.96M |
| Price to Earnings Ratio | -3.81 |
| Price to Sales Ratio | 2.89k |
| Price to Cash Ratio | 8.81 |
| Price to Book Ratio | 2.05 |
| Dividend Yield | - |
| Shares Outstanding | 63.89M |
| Average Volume (1 week) | 633.73k |
| Average Volume (1 Month) | 951.32k |
| 52 Week Change | -26.60% |
| 52 Week High | 24.18 |
| 52 Week Low | 10.925 |
| Spread (Intraday) | 6.85 (46.13%) |
| Company Name | Viridian Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.viridiantherapeutics.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
